|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 256.00 EUR | -0.23% |
|
+2.52% | +7.29% |
| 25/06 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 22/06 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.23% | +2.52% | +4.79% | +1.87% | +7.29% | +51.66% | +216.28% | +189.27% | +311.18% | 5.56TCr | |
| -0.53% | +1.67% | -2.93% | -17.26% | -19.66% | +19.19% | -20.47% | +12.64% | +82.67% | 6.31TCr | |
| +0.07% | +38.60% | +38.60% | +38.60% | +38.60% | +38.60% | +38.60% | +38.60% | - | 4.16TCr | |
| -2.36% | -1.25% | +18.54% | -20.42% | -33.47% | -52.13% | -58.98% | -60.17% | +5.56% | 3.9TCr | |
| +1.19% | +2.74% | +4.23% | +6.76% | +14.76% | +58.64% | -29.02% | -41.95% | -11.82% | 2.98TCr | |
| -1.11% | -6.58% | +27.45% | +11.60% | +102.61% | +122.45% | -49.58% | -72.83% | - | 2.37TCr | |
| -0.86% | +9.48% | +10.67% | +16.59% | +8.87% | +59.19% | +72.19% | +23.84% | +39.69% | 2.15TCr | |
| -1.25% | -0.27% | -5.89% | -5.35% | -1.44% | -4.39% | +142.42% | -19.45% | - | 1.69TCr | |
| -2.02% | +3.69% | +5.06% | +20.42% | +38.58% | +65.90% | +121.73% | +203.32% | +374.24% | 1.67TCr | |
| +0.48% | +5.16% | +0.82% | -2.68% | -8.89% | +57.03% | +345.02% | +15.29% | - | 1.36TCr | |
| +0.94% | +1.49% | +2.88% | +4.60% | -16.57% | -3.85% | +787.57% | +440.87% | +7,484.27% | 1.3TCr | |
| -0.25% | -5.26% | +0.58% | +46.70% | +29.94% | +128.86% | +169.36% | +222.90% | +3,242.68% | 1.22TCr | |
| +0.03% | +4.86% | +6.03% | +3.17% | -3.50% | +5.93% | -38.66% | -32.36% | -25.53% | 1.11TCr | |
| +3.54% | +3.41% | +20.20% | +41.18% | +45.99% | +152.58% | +201.20% | +431.89% | - | 1.06TCr | |
| -1.32% | -1.03% | -6.28% | +3.95% | -15.81% | -12.12% | -21.50% | -60.56% | -51.63% | 627.46Cr | |
| +5.80% | +10.38% | +59.57% | +98.70% | +204.70% | +161.29% | +459.32% | -21.14% | - | 601.85Cr | |
| +3.78% | +10.83% | +6.04% | -7.74% | +8.32% | +18.39% | +288.47% | +215.83% | - | 586.85Cr | |
| -0.93% | -1.12% | -12.87% | -26.75% | -34.20% | -27.52% | +109.34% | +62.51% | +112.13% | 512.21Cr | |
| +0.18% | -3.82% | -22.37% | -31.12% | -38.92% | -55.69% | -58.78% | -78.15% | - | 510.71Cr | |
| -0.46% | -0.02% | +5.86% | -4.09% | -16.72% | +4.25% | +53.34% | -51.21% | - | 496.5Cr | |
| Average | +0.24% | +2.91% | +8.05% | +8.94% | +15.52% | +39.41% | +136.39% | +70.96% | +1,051.22% | 2.01TCr | |
| Weighted average by Cap. | -0.25% | +2.93% | +9.81% | +5.56% | +10.84% | +37.81% | +93.54% | +61.02% | +609.39% |
- Stock Market
- Stocks
- UCB Stock
- Sector UCB
Select your edition
All financial news and data tailored to specific country editions
